Marina Talamonti

Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?

Impact of Upadacitinib on Atopic Keratoconjunctivitis Exacerbated by Dupilumab Treatment in Atopic Dermatitis Patients: A Prospective Dermatological and Ophthalmological Clinical Evaluation in Common Clinical Practice

Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy

Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104‐week multicenter retrospective study – <scp>IL PSO</scp> (<scp>ITALIAN LANDSCAPE PSORIASIS</scp>)

Integrated Clinical-Molecular Classification of Colorectal Liver Metastases

Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study

Development of a Two-Week Dedicated Robotic Surgery Curriculum for General Surgery Residents

Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study

Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study

Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study

Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study

Management of biological therapies for chronic plaque psoriasis during COVID‐19 emergency in Italy

The Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection

Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis

Minimally invasive pancreatoduodenectomy: is the incidence of clinically relevant postoperative pancreatic fistula comparable to that after open pancreatoduodenectomy?

Italian guidelines on the systemic treatments of moderate‐to‐severe plaque psoriasis

Using the NSQIP Pancreatic Demonstration Project to Derive a Modified Fistula Risk Score for Preoperative Risk Stratification in Patients Undergoing Pancreaticoduodenectomy

Management of Incidental Liver Lesions on CT: A White Paper of the ACR Incidental Findings Committee

Laparoscopic Distal Pancreatectomy for Cancer Provides Oncologic Outcomes and Overall Survival Identical to Open Distal Pancreatectomy

Time to Initiation of Adjuvant Chemotherapy in Pancreas Cancer: A Multi-Institutional Experience

Minimally invasive pancreatic resections: cost and value perspectives

Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study

Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer

A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy

Laparoscopic pancreaticoduodenectomy for adenocarcinoma provides short-term oncologic outcomes and long-term overall survival rates similar to those for open pancreaticoduodenectomy

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base

Educating surgeons on intraoperative disposable supply costs during laparoscopic cholecystectomy: a regional health system's experience

Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma